Filgrastim-sndz (Zarxio) - Oncology Nurse Advisor

Filgrastim-sndz (Zarxio)

Slideshow

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

This slideshow reviews filgrastim-sndz (Zarxio), indicated to decrease the incidence of infection for patients receiving myelosuppressive anticancer drugs and also to reduce the time to neutrophil recovery and fever duration following induction or consolidation chemotherapy treatment for acute myeloid leukemia.

Next hm-slideshow in Slides